Ferentis is a research-intensive biotechnology company involved in the development, production and commercialization of biomimetic peptides and peptide-based scaffolds for tissue engineering and regenerative medicine applications. Ferentis was established in Vilnius, Lithuania, by a group of scientists and entrepreneurs from Canada, Lithuania, Sweden and India.